Refining frailty in relapsed or refractory multiple myeloma: adding the patient voice
- PMID: 36102770
- DOI: 10.1016/S2666-7568(22)00192-1
Refining frailty in relapsed or refractory multiple myeloma: adding the patient voice
Conflict of interest statement
KLS reports funding from the American Society of Hematology. TMW reports funding from Janssen and Sanofi.
Comment on
-
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.Lancet Healthy Longev. 2022 Sep;3(9):e628-e635. doi: 10.1016/S2666-7568(22)00172-6. Lancet Healthy Longev. 2022. PMID: 36102777
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical